Literature DB >> 12616591

Olanzapine treatment of anorexia nervosa: a retrospective study.

Amanda Malina1, Jill Gaskill, Claire McConaha, Guido K Frank, Maria LaVia, Lisa Scholar, Walter H Kaye.   

Abstract

BACKGROUND: Recent reports raise the possibility that olanzapine, which commonly causes weight gain in non-eating-disordered subjects, assisted weight gain and mood during refeeding in anorexia nervosa (AN) patients.
METHODS: Eighteen AN subjects who engaged in open treatment with olanzapine were retrospectively questioned about their response.
RESULTS: Subjects reported a significant reduction in anxiety, difficulty eating, and core eating disorder symptoms after taking olanzapine. DISCUSSION: These data lend support to the possibility that olanzapine may be useful in AN patients.
CONCLUSION: A controlled trial is necessary to prove that olanzapine is efficacious. Copyright 2003 by Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12616591     DOI: 10.1002/eat.10122

Source DB:  PubMed          Journal:  Int J Eat Disord        ISSN: 0276-3478            Impact factor:   4.861


  12 in total

1.  Challenges associated with controlled psychopharmacological research trials in adolescents with eating disorders.

Authors:  Mark L Norris; Wendy Spettigue; Annick Buchholz; Katherine A Henderson
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2007-11

Review 2.  The Role of Psychotropic Medications in the Management of Anorexia Nervosa: Rationale, Evidence and Future Prospects.

Authors:  Guido K W Frank; Megan E Shott
Journal:  CNS Drugs       Date:  2016-05       Impact factor: 5.749

3.  Differential weight restoration on olanzapine versus fluoxetine in identical twins with anorexia nervosa.

Authors:  Vikas Duvvuri; Taya Cromley; Megan Klabunde; Kerri Boutelle; Walter H Kaye
Journal:  Int J Eat Disord       Date:  2011-02-22       Impact factor: 4.861

Review 4.  Interacting Neural Processes of Feeding, Hyperactivity, Stress, Reward, and the Utility of the Activity-Based Anorexia Model of Anorexia Nervosa.

Authors:  Rachel A Ross; Yael Mandelblat-Cerf; Anne M J Verstegen
Journal:  Harv Rev Psychiatry       Date:  2016 Nov/Dec       Impact factor: 3.732

Review 5.  The psychopharmacotherapy of anorexia nervosa: clinical, neuroendocrine and metabolic aspects.

Authors:  G Abbate Daga; L Gianotti; V Mondelli; R Quartesan; S Fassino
Journal:  J Endocrinol Invest       Date:  2004-11       Impact factor: 4.256

Review 6.  Eating disorders and psychosis: Seven hypotheses.

Authors:  Mary V Seeman
Journal:  World J Psychiatry       Date:  2014-12-22

7.  Tolerability and efficacy of aripiprazole in a case of psychotic anorexia nervosa comorbid with epilepsy and chronic renal failure.

Authors:  M Aragona
Journal:  Eat Weight Disord       Date:  2007-09       Impact factor: 4.652

Review 8.  Nothing tastes as good as skinny feels: the neurobiology of anorexia nervosa.

Authors:  Walter H Kaye; Christina E Wierenga; Ursula F Bailer; Alan N Simmons; Amanda Bischoff-Grethe
Journal:  Trends Neurosci       Date:  2013-01-18       Impact factor: 13.837

9.  A review of medication use for children and adolescents with eating disorders.

Authors:  Jennifer Couturier; James Lock
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2007-11

10.  Evaluation of the Effectiveness and Safety of Olanzapine as an Adjunctive Treatment for Anorexia Nervosa in Adolescents: An Open-Label Trial.

Authors:  Wendy Spettigue; Mark L Norris; Danijela Maras; Nicole Obeid; Stephen Feder; Megan E Harrison; Rebecca Gomez; Maeghan Cy Fu; Katherine Henderson; Annick Buchholz
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2018-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.